- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Lenalidomide – March 2019
Lenalidomide: Capsule 5 mg, Capsule 10 mg, Capsule 15 mg, Capsule 25 mg; Revlimid®
Last updated
19 July 2019